Tourmaline Bio to Present at the Guggenheim Securities SMID Cap Biotech Conference
27. Januar 2025 07:00 ET
|
Tourmaline Bio, Inc.
NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve...
Tourmaline Strengthens Cardiovascular Scientific Advisory Board with Appointment of Dr. Paul M. Ridker
10. Januar 2025 07:30 ET
|
Tourmaline Bio, Inc.
Paul M. Ridker, MD, MPH, has joined Tourmaline’s Cardiovascular Scientific Advisory Board (CV SAB).
Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day
10. Dezember 2024 08:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
14. November 2024 07:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
07. November 2024 07:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Tourmaline Bio to Present at Upcoming Investor Conferences
31. Oktober 2024 07:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio to Present at Upcoming Investor Conferences
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
15. Oktober 2024 07:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
11. Oktober 2024 07:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
08. Oktober 2024 07:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
Tourmaline Bio to Present at Upcoming Investor Conferences
03. September 2024 07:45 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio to Present at Upcoming Investor Conferences